Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1940935

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1940935

Cancer Biopsy Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global cancer biopsy market is experiencing robust growth, driven by rising cancer incidence, advancements in diagnostic technologies, and increasing adoption of personalized medicine. Cancer biopsies are a critical tool in the early detection, diagnosis, and management of cancer, enabling physicians to tailor treatment strategies based on the unique characteristics of a patient's tumor. The market, valued at USD 35.8 billion in 2026, is projected to reach USD 58.8 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.20% during the forecast period.

Market Insights

Early and accurate cancer diagnosis is essential for improving patient outcomes, and biopsy procedures remain the gold standard for determining the presence and type of cancer. Traditional tissue biopsies are being complemented and, in some cases, replaced by minimally invasive techniques such as liquid biopsies, which analyze circulating tumor DNA and other biomarkers from blood samples. These advances are driving a shift toward precision oncology, allowing clinicians to monitor disease progression, evaluate treatment response, and detect recurrence in real time. Additionally, the rising prevalence of chronic diseases and increasing cancer awareness are contributing to greater adoption of biopsy services worldwide.

Market Drivers

Several factors are fueling the growth of the global cancer biopsy market:

  • Rising Prevalence of Cancer: The global burden of cancer continues to grow, with breast, lung, colorectal, and prostate cancers being the most commonly diagnosed. This has led to increased demand for accurate and timely diagnostic methods.
  • Technological Advancements: The development of advanced biopsy instruments, kits, and consumables has improved the precision and safety of both tissue and liquid biopsies. Imaging-guided techniques and automated systems further enhance diagnostic accuracy.
  • Demand for Personalized Medicine: Biopsies provide critical molecular and genetic information, enabling oncologists to design personalized treatment regimens that improve patient outcomes.
  • Expanding Healthcare Infrastructure: Investments in healthcare facilities, particularly in emerging regions, are making advanced biopsy procedures more accessible.
  • Awareness and Screening Programs: Government initiatives and public health campaigns promoting early cancer detection have increased patient awareness, leading to higher biopsy adoption rates.

Business Opportunities

The cancer biopsy market presents significant opportunities for companies operating in diagnostics, healthcare services, and biotechnology. Liquid biopsy technologies, in particular, offer a platform for innovation due to their non-invasive nature and potential for early cancer detection. Companies focusing on research and development to enhance the sensitivity, specificity, and reliability of biopsy instruments and kits can establish a competitive edge. Additionally, entering emerging markets with rising cancer incidence and growing healthcare expenditure provides ample growth potential. Collaborations with hospitals, diagnostic laboratories, and research institutions can further strengthen market presence and drive revenue generation.

Regional Analysis

The cancer biopsy market shows distinct trends across regions:

  • North America: The region dominates the market, supported by advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and a well-established oncology ecosystem. The U.S. and Canada are key contributors, driven by extensive research and development activities.
  • Europe: Europe demonstrates steady growth, fueled by government initiatives promoting early detection, advanced healthcare systems, and widespread adoption of minimally invasive biopsy procedures. Germany, the U.K., and France are major contributors.
  • Asia Pacific: Rapid market growth is expected in the Asia Pacific region due to increasing population, rising cancer incidence, expanding healthcare infrastructure, and growing awareness about cancer diagnostics. China, India, and Japan are key markets.
  • Latin America: The market is growing steadily, supported by rising healthcare investment, improving diagnostic capabilities, and awareness programs promoting early cancer detection.
  • Middle East & Africa: Gradual market growth is observed in this region, driven by expanding healthcare facilities, government initiatives, and increased investment in diagnostic technologies.

Key Players

The cancer biopsy market is competitive, with several major companies leading product development and market expansion. Prominent players include:

  • Hologic, Inc.
  • Becton, Dickinson and Company (BD)
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Medtronic plc
  • Stryker Corporation
  • Olympus Corporation
  • Boston Scientific Corporation
  • COOK Medical (Cook Group)
  • Pfizer Inc. (through biopsy product portfolio)
  • Merit Medical Systems, Inc.
  • CONMED Corporation
  • Argon Medical Devices, Inc.
  • F. Hoffmann-La Roche Ltd (Roche Diagnostics)
  • QIAGEN

These companies focus on technological innovation, strategic partnerships, and regional expansion to strengthen their market position and capitalize on growing demand.

Market Segmentation

The cancer biopsy market can be segmented by product, type, application, and region as follows:

Product:

  • Instruments
  • Kits & Consumables
  • Services

Type:

  • Tissue Biopsies
  • Liquid Biopsies
  • Others

Application:

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Prostate Cancers
  • Skin Cancers
  • Blood Cancers
  • Kidney Cancers
  • Liver Cancers
  • Pancreatic Cancers
  • Ovarian Cancers
  • Others

Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Cancer Biopsy Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Cancer Biopsy Market Outlook, 2020-2033

  • 3.1. Global Cancer Biopsy Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 3.1.1. Instruments
    • 3.1.2. Kits & Consumables
    • 3.1.3. Services
  • 3.2. Global Cancer Biopsy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 3.2.1. Tissue Biopsies
    • 3.2.2. Liquid Biopsies
    • 3.2.3. Others
  • 3.3. Global Cancer Biopsy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.3.1. Breast Cancer
    • 3.3.2. Colorectal Cancer
    • 3.3.3. Cervical Cancers
    • 3.3.4. Lung Cancers
    • 3.3.5. Prostate Cancers
    • 3.3.6. Skin Cancers
    • 3.3.7. Blood Cancers
    • 3.3.8. Kidney Cancers
    • 3.3.9. Liver Cancers
    • 3.3.10. Pancreatic Cancers
  • 3.4. Global Cancer Biopsy Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Cancer Biopsy Market Outlook, 2020-2033

  • 4.1. North America Cancer Biopsy Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 4.1.1. Instruments
    • 4.1.2. Kits & Consumables
    • 4.1.3. Services
  • 4.2. North America Cancer Biopsy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 4.2.1. Tissue Biopsies
    • 4.2.2. Liquid Biopsies
    • 4.2.3. Others
  • 4.3. North America Cancer Biopsy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.3.1. Breast Cancer
    • 4.3.2. Colorectal Cancer
    • 4.3.3. Cervical Cancers
    • 4.3.4. Lung Cancers
    • 4.3.5. Prostate Cancers
    • 4.3.6. Skin Cancers
    • 4.3.7. Blood Cancers
    • 4.3.8. Kidney Cancers
    • 4.3.9. Liver Cancers
    • 4.3.10. Pancreatic Cancers
  • 4.4. North America Cancer Biopsy Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 4.4.2. U.S. Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 4.4.3. U.S. Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 4.4.4. Canada Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 4.4.5. Canada Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 4.4.6. Canada Cancer Biopsy Market Outlook, by Application, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Cancer Biopsy Market Outlook, 2020-2033

  • 5.1. Europe Cancer Biopsy Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 5.1.1. Instruments
    • 5.1.2. Kits & Consumables
    • 5.1.3. Services
  • 5.2. Europe Cancer Biopsy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 5.2.1. Tissue Biopsies
    • 5.2.2. Liquid Biopsies
    • 5.2.3. Others
  • 5.3. Europe Cancer Biopsy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.3.1. Breast Cancer
    • 5.3.2. Colorectal Cancer
    • 5.3.3. Cervical Cancers
    • 5.3.4. Lung Cancers
    • 5.3.5. Prostate Cancers
    • 5.3.6. Skin Cancers
    • 5.3.7. Blood Cancers
    • 5.3.8. Kidney Cancers
    • 5.3.9. Liver Cancers
    • 5.3.10. Pancreatic Cancers
  • 5.4. Europe Cancer Biopsy Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 5.4.2. Germany Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 5.4.3. Germany Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 5.4.4. Italy Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 5.4.5. Italy Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 5.4.6. Italy Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 5.4.7. France Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 5.4.8. France Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 5.4.9. France Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 5.4.10. U.K. Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 5.4.11. U.K. Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 5.4.12. U.K. Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 5.4.13. Spain Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 5.4.14. Spain Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 5.4.15. Spain Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 5.4.16. Russia Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 5.4.17. Russia Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 5.4.18. Russia Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 5.4.19. Rest of Europe Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 5.4.20. Rest of Europe Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 5.4.21. Rest of Europe Cancer Biopsy Market Outlook, by Application, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cancer Biopsy Market Outlook, 2020-2033

  • 6.1. Asia Pacific Cancer Biopsy Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 6.1.1. Instruments
    • 6.1.2. Kits & Consumables
    • 6.1.3. Services
  • 6.2. Asia Pacific Cancer Biopsy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 6.2.1. Tissue Biopsies
    • 6.2.2. Liquid Biopsies
    • 6.2.3. Others
  • 6.3. Asia Pacific Cancer Biopsy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.3.1. Breast Cancer
    • 6.3.2. Colorectal Cancer
    • 6.3.3. Cervical Cancers
    • 6.3.4. Lung Cancers
    • 6.3.5. Prostate Cancers
    • 6.3.6. Skin Cancers
    • 6.3.7. Blood Cancers
    • 6.3.8. Kidney Cancers
    • 6.3.9. Liver Cancers
    • 6.3.10. Pancreatic Cancers
  • 6.4. Asia Pacific Cancer Biopsy Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 6.4.2. China Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 6.4.3. China Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 6.4.4. Japan Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 6.4.5. Japan Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 6.4.6. Japan Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 6.4.7. South Korea Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 6.4.8. South Korea Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 6.4.9. South Korea Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 6.4.10. India Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 6.4.11. India Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 6.4.12. India Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 6.4.13. Southeast Asia Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 6.4.14. Southeast Asia Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 6.4.15. Southeast Asia Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 6.4.16. Rest of SAO Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 6.4.17. Rest of SAO Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 6.4.18. Rest of SAO Cancer Biopsy Market Outlook, by Application, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Cancer Biopsy Market Outlook, 2020-2033

  • 7.1. Latin America Cancer Biopsy Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 7.1.1. Instruments
    • 7.1.2. Kits & Consumables
    • 7.1.3. Services
  • 7.2. Latin America Cancer Biopsy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 7.2.1. Tissue Biopsies
    • 7.2.2. Liquid Biopsies
    • 7.2.3. Others
  • 7.3. Latin America Cancer Biopsy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.3.1. Breast Cancer
    • 7.3.2. Colorectal Cancer
    • 7.3.3. Cervical Cancers
    • 7.3.4. Lung Cancers
    • 7.3.5. Prostate Cancers
    • 7.3.6. Skin Cancers
    • 7.3.7. Blood Cancers
    • 7.3.8. Kidney Cancers
    • 7.3.9. Liver Cancers
    • 7.3.10. Pancreatic Cancers
  • 7.4. Latin America Cancer Biopsy Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 7.4.2. Brazil Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 7.4.3. Brazil Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 7.4.4. Mexico Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 7.4.5. Mexico Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 7.4.6. Mexico Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 7.4.7. Argentina Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 7.4.8. Argentina Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 7.4.9. Argentina Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 7.4.10. Rest of LATAM Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 7.4.11. Rest of LATAM Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 7.4.12. Rest of LATAM Cancer Biopsy Market Outlook, by Application, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Cancer Biopsy Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Cancer Biopsy Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 8.1.1. Instruments
    • 8.1.2. Kits & Consumables
    • 8.1.3. Services
  • 8.2. Middle East & Africa Cancer Biopsy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 8.2.1. Tissue Biopsies
    • 8.2.2. Liquid Biopsies
    • 8.2.3. Others
  • 8.3. Middle East & Africa Cancer Biopsy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.3.1. Breast Cancer
    • 8.3.2. Colorectal Cancer
    • 8.3.3. Cervical Cancers
    • 8.3.4. Lung Cancers
    • 8.3.5. Prostate Cancers
    • 8.3.6. Skin Cancers
    • 8.3.7. Blood Cancers
    • 8.3.8. Kidney Cancers
    • 8.3.9. Liver Cancers
    • 8.3.10. Pancreatic Cancers
  • 8.4. Middle East & Africa Cancer Biopsy Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 8.4.2. GCC Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 8.4.3. GCC Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 8.4.4. South Africa Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 8.4.5. South Africa Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 8.4.6. South Africa Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 8.4.7. Egypt Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 8.4.8. Egypt Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 8.4.9. Egypt Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 8.4.10. Nigeria Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 8.4.11. Nigeria Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 8.4.12. Nigeria Cancer Biopsy Market Outlook, by Application, 2020-2033
    • 8.4.13. Rest of Middle East Cancer Biopsy Market Outlook, by Product, 2020-2033
    • 8.4.14. Rest of Middle East Cancer Biopsy Market Outlook, by Type, 2020-2033
    • 8.4.15. Rest of Middle East Cancer Biopsy Market Outlook, by Application, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Hologic, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Becton, Dickinson and Company (BD)
    • 9.4.3. Thermo Fisher Scientific Inc.
    • 9.4.4. Danaher Corporation
    • 9.4.5. Medtronic plc
    • 9.4.6. Stryker Corporation
    • 9.4.7. Olympus Corporation
    • 9.4.8. Boston Scientific Corporation
    • 9.4.9. COOK Medical (Cook Group)
    • 9.4.10. Pfizer Inc. (through biopsy product portfolio)

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!